Peloton Wealth Strategists’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93K | Hold |
25,000
| – | – | 0.04% | 89 |
|
|
2025
Q1 | $81K | Hold |
25,000
| – | – | 0.03% | 92 |
|
|
2024
Q4 | $139K | Hold |
25,000
| – | – | 0.06% | 92 |
|
|
2024
Q3 | $270K | Hold |
25,000
| – | – | 0.11% | 89 |
|
|
2024
Q2 | $525K | Hold |
25,000
| – | – | 0.22% | 76 |
|
|
2024
Q1 | $797K | Hold |
25,000
| – | – | 0.32% | 68 |
|
|
2023
Q4 | $507K | Hold |
25,000
| – | – | 0.22% | 76 |
|
|
2023
Q3 | $318K | Buy |
+25,000
| New | +$318K | 0.15% | 83 |
|
|
2023
Q2 | – | Sell |
-16,000
| Closed | -$275K | – | 89 |
|
|
2023
Q1 | $275K | Sell |
16,000
-21,000
| -57% | -$361K | 0.13% | 81 |
|
|
2022
Q4 | $822K | Sell |
37,000
-14,000
| -27% | -$311K | 0.4% | 65 |
|
|
2022
Q3 | $410K | Buy |
51,000
+20,386
| +67% | +$164K | 0.21% | 72 |
|
|
2022
Q2 | $214K | Buy |
+30,614
| New | +$214K | 0.1% | 85 |
|